Drug Type Small molecule drug |
Synonyms EP |
Target |
Action inhibitors |
Mechanism NTCP inhibitors(Sodium/bile acid cotransporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H44O3 |
InChIKeyVXOZCESVZIRHCJ-KGHQQZOUSA-N |
CAS Registry2061-64-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | China | 01 Jul 2024 | |
Liver Cancer | Preclinical | China | 01 Jun 2024 | |
Hepatitis D | Preclinical | Taiwan Province | 01 Jan 2024 |